Erectile dysfunction in the 21st century: whom we can treat, whom we cannot treat and patient education

被引:13
作者
Carson, CC [1 ]
机构
[1] Univ N Carolina, Div Urol, Chapel Hill, NC 27599 USA
关键词
erectile dysfunction; diagnosis; treatment; combination therapy;
D O I
10.1038/sj.ijir.3900804
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Erectile dysfunction affects 31-52% of American men. Although considerable advances have been made in the diagnosis and treatment of erectile dysfunction in the past decade, more than 80% of men with erectile dysfunction are not treated because they do not seek medical attention or their physicians do not initiate a dialogue about sexual problems during their visits. This despite patients' desires to confront sexual problems and receive treatment. Most subgroups of men can now be effectively treated for sexual dysfunction. Although men with severe cardiac disease may require stabilization of their cardiac condition before treatment, most can successfully return to an active sex life. Some men, however, do not respond to the use of oral agents. These men can be treated with second- and third-line treatment modalities or with the newer concept of combined-modality treatment. Despite excellent treatment alternatives, many men have low libido or hypoactive sexual desire disorder. In the ultimate resolution of a patient's sexual dysfunction, physicians must open a free and sympathetic dialogue and offer a full spectrum of treatment modalities tailored to the individual patient and partner. If initial treatment modalities fail, more invasive alternatives or combination therapy should be offered to cure the patient's erectile dysfunction.
引用
收藏
页码:S29 / S34
页数:6
相关论文
共 28 条
[1]   Intraurethral application of alprostadil in patients with failed inflatable penile prosthesis [J].
Benevides, MD ;
Carson, CC .
JOURNAL OF UROLOGY, 2000, 163 (03) :785-787
[2]   Physician-patient dialogue and clinical evaluation of erectile dysfunction [J].
Chun, J ;
Carson, CC .
UROLOGIC CLINICS OF NORTH AMERICA, 2001, 28 (02) :249-+
[3]  
DeBusk R, 2000, AM J CARDIOL, V86, p62F
[4]   Modifiable risk factors and erectile dysfunction: Can lifestyle changes modify risk? [J].
Derby, CA ;
Mohr, BA ;
Goldstein, I ;
Feldman, HA ;
Johannes, CB ;
McKinlay, JB .
UROLOGY, 2000, 56 (02) :302-306
[5]   IMPOTENCE AND ITS MEDICAL AND PSYCHOSOCIAL CORRELATES - RESULTS OF THE MASSACHUSETTS MALE AGING STUDY [J].
FELDMAN, HA ;
GOLDSTEIN, I ;
HATZICHRISTOU, DG ;
KRANE, RJ ;
MCKINLAY, JB .
JOURNAL OF UROLOGY, 1994, 151 (01) :54-61
[6]  
Fowler C, 1999, ANN NEUROL, V46, P497
[7]   Oral sildenafil in the treatment of erectile dysfunction [J].
Goldstein, I ;
Lue, TF ;
Padma-Nathan, H ;
Rosen, RC ;
Steers, WD ;
Wicker, PA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (20) :1397-1404
[8]   Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment [J].
Jarow, JP ;
Burnett, AL ;
Geringer, AM .
JOURNAL OF UROLOGY, 1999, 162 (03) :722-725
[9]   Sexual dysfunction in the United States - Prevalence and predictors [J].
Laumann, EO ;
Paik, A ;
Rosen, RC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (06) :537-544
[10]   Microcirculatory dysfunction induced by cigarette smoking [J].
Lehr, HA .
MICROCIRCULATION, 2000, 7 (06) :367-384